IRIS
MOROSINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.031
EU - Europa 752
AS - Asia 455
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
SA - Sud America 1
Totale 2.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.023
CN - Cina 402
IE - Irlanda 272
FI - Finlandia 115
UA - Ucraina 108
DE - Germania 83
IT - Italia 78
SE - Svezia 39
GB - Regno Unito 34
SG - Singapore 34
JP - Giappone 12
FR - Francia 10
CA - Canada 8
BE - Belgio 6
EU - Europa 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
IR - Iran 2
RU - Federazione Russa 2
AL - Albania 1
AZ - Azerbaigian 1
EC - Ecuador 1
IN - India 1
MU - Mauritius 1
NL - Olanda 1
PL - Polonia 1
TH - Thailandia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 2.245
Salva come PNG Salva come JPEG
Città #
Dublin 272
Chandler 251
Jacksonville 133
Ashburn 98
Nanjing 91
Beijing 81
Boardman 64
Helsinki 63
Princeton 41
Lawrence 38
Nanchang 37
New York 36
Pavia 33
Shenyang 33
Wilmington 31
Hebei 30
Shanghai 30
Medford 29
Changsha 26
Jiaxing 23
Singapore 19
Ann Arbor 16
Hangzhou 16
Tianjin 16
Los Angeles 15
Washington 13
Tokyo 12
Seattle 11
Milan 10
Verona 10
Woodbridge 10
Piscataway 8
Fairfield 7
Brussels 6
Toronto 6
Auburn Hills 4
Ningbo 4
Norwalk 4
Taizhou 4
Berlin 3
Falkenstein 3
Houston 3
Jinan 3
Munich 3
Trieste 3
Bari 2
Brescia 2
Brno 2
Dallas 2
Gallarate 2
Ostuni 2
Romainville 2
Settimo Torinese 2
Amsterdam 1
Aosta 1
Baku 1
Bangkok 1
Busto Arsizio 1
Clifton 1
Des Moines 1
Esslingen am Neckar 1
Fuzhou 1
Gropello Cairoli 1
Gunzenhausen 1
Hanoi 1
Kemerovo 1
Kunming 1
Leawood 1
London 1
Markham 1
Ottawa 1
Pune 1
Quito 1
Redwood City 1
Rockville 1
Santa Clara 1
Tappahannock 1
Tashkent 1
Tehran 1
Tirana 1
Wenzhou 1
Zhengzhou 1
Totale 1.694
Salva come PNG Salva come JPEG
Nome #
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 93
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 86
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 79
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 78
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 75
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 74
Specific Anti-CMV Reactivity in BAL: A Useful Tool 74
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 72
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 71
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 67
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 67
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 66
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis 65
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 61
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 61
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 61
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 59
Possible Disease Markers in BAL Fluid of BOS Patients 58
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 57
A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999 57
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 56
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 56
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 56
Regulatory T cells in kidney transplant recipients. 55
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 54
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 53
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 51
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 51
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 50
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 49
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 48
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 46
Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis 46
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 42
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 42
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients 39
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 38
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 32
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 29
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 15
Totale 2.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020170 0 0 0 18 0 19 10 22 0 64 37 0
2020/2021219 26 17 6 21 2 31 3 47 7 30 24 5
2021/2022155 8 0 4 3 0 3 2 6 11 6 25 87
2022/2023731 72 67 2 58 61 74 0 38 326 6 18 9
2023/2024385 60 64 18 17 24 99 10 33 1 20 15 24
2024/2025100 26 48 22 4 0 0 0 0 0 0 0 0
Totale 2.289